Mattei A - EpiVax, Inc. - Informatics and Immunology

Innovative Preclinical Assessment Tools for Safety and Efficacy of Protein and Peptide Therapeutics … Of Peptides and P-ANDAS A Case Study of Taspoglutide

Innovative Preclinical Assessment Tools for Safety and Efficacy of Protein and Peptide Therapeutics … Of Peptides and P-ANDAS A Case Study of Taspoglutide

by Danielle Medeiros | Sep 9, 2019

EpiVax_PANDA_Taspoglutide_April_19_Final

Predicting Immunogenicity of Peptide Drugs and Their Impurities Using in Silico Tools: Taspoglutide Case Study

Predicting Immunogenicity of Peptide Drugs and Their Impurities Using in Silico Tools: Taspoglutide Case Study

by Kathleen Gonzalez | May 15, 2019

EpiVax_TaspoglutidePoster_14May19

Modeling HLA Binding and “Self” Conservation Using In Silico Tools Predicts Immunogenic T Cell Epitopes in Vaccinated Individuals

Modeling HLA Binding and “Self” Conservation Using In Silico Tools Predicts Immunogenic T Cell Epitopes in Vaccinated Individuals

by Kathleen Gonzalez | Oct 9, 2018

EpiVax_ISV2018_HLA Binding and Self Conservation_4Oct18

In Silico Screening and Immune-Engineering Techniques for “Stealth” Receptor Targets of Immunotherapeutic Antibodies

In Silico Screening and Immune-Engineering Techniques for “Stealth” Receptor Targets of Immunotherapeutic Antibodies

by Kathleen Gonzalez | Oct 5, 2018

EpiVax_CPI-Targets_04Oct18_forPrinting

HLA Binding Assay Design: Impact of HLA binding motif centering on HLA binding results and T cell response; Relevance to Overlapping Peptide Analysis

HLA Binding Assay Design: Impact of HLA binding motif centering on HLA binding results and T cell response; Relevance to Overlapping Peptide Analysis

by Kathleen Gonzalez | Oct 5, 2018

EpiVax_ISV2018_HLA-offCenter_04Oct18 (002)